Novartis | NOVN - Current Assets

Stock Price
116.88
Daily Change
-0.36 -0.31%
Monthly
7.72%
Yearly
22.27%
Q1 Forecast
111.83

Novartis reported $28.2B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 28.54B 722M Sep/2025
Alcon AG USD 6.33B 27M Sep/2025
Almirall EUR 714.05M 27.09M Jun/2025
Amgen USD 27.88B 1.15B Sep/2025
AstraZeneca USD 29.94B 1B Sep/2025
Autolus Therapeutics Ltd USD 514.58M 59.67M Sep/2025
Bayer EUR 32.88B 873M Sep/2025
Biogen USD 8.94B 968.9M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
Fresenius EUR 12.06B 1.18B Sep/2025
Fresenius Medical Care EUR 7.82B 311.36M Sep/2025
Galapagos EUR 3.16B 93.29M Sep/2025
Genmab DKK 3.91B 127M Jun/2025
Gilead Sciences USD 18.84B 4.12B Sep/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
GRIFOLS EUR 5.35B 102.57M Sep/2025
Hikma Pharmaceutical USD 2.56B 294M Jun/2025
J&J USD 54.61B 113M Sep/2025
Lonza CHF 5.44B 113M Dec/2024
Merck EUR 12.88B 680M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Novo Nordisk DKK 181.88B 19.18B Sep/2025
Orion EUR 1.1B 89.6M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Philips EUR 9.28B 215M Sep/2025
Recordati EUR 1.71B 144.32M Sep/2025
Regeneron Pharmaceuticals USD 17.98B 1.12B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
UCB EUR 4.79B 1.47B Dec/2024